Monday, 1 April 2019

Sichuan Haisco invests in Clal Biotech's eXithera - Globes

Sichuan Haisco invests in Clal Biotech's eXithera  Globes

Sichuan Haisco has received an exclusive license to develop, manufacture, and market eXithera's new anti-coagulant in China.

No comments:

Post a Comment